4521. Atrial Endocardial Unipolar Voltage Mapping for Detection of Viable Intramural Myocardium: A Proof-of-Concept Study.
作者: Hagai Yavin.;Arwa Younis.;Israel Zilberman.;Alison Krywanczyk.;Zachary P Bubar.;Koji Higuchi.;Michael Barkagan.;Elad Anter.
来源: Circ Arrhythm Electrophysiol. 2023年16卷1期e011321页
Endocardial bipolar voltage amplitude is largely derived from endocardial and subendocardial wall layers. This may result in situations of low bipolar voltage amplitude despite the presence of mid-myocardial including epicardial (ie, intramural-epicardial) viable myocardium. This study examined the utility of endocardial unipolar voltage mapping for detection of viable intramural-epicardial atrial myocardium.
4522. Electrophysiology, Pathology, and Imaging of Pulsed Field Ablation of Scarred and Healthy Ventricles in Swine.
作者: Iwanari Kawamura.;Vivek Y Reddy.;Carlos G Santos-Gallego.;Bingyan J Wang.;Hina W Chaudhry.;Eric D Buck.;George Mavroudis.;Samantha Jerrell.;Christopher W Schneider.;Molly Speltz.;Srinivas R Dukkipati.;Jacob S Koruth.
来源: Circ Arrhythm Electrophysiol. 2023年16卷1期e011369页
Pulsed field ablation (PFA) has recently been shown to penetrate ischemic scar, but details on its efficacy, risk of arrhythmias, and imaging insights are lacking. In a porcine model of myocardial scar, we studied the ability of ventricular PFA to penetrate scarred tissue, induce ventricular arrhythmias, and assess the influence of QRS gating during pulse delivery.
4523. Chronic Kidney Disease Induces Proarrhythmic Remodeling.
作者: Benjamin M N King.;Shana Mintz.;Xianming Lin.;Gregory E Morley.;Florencia Schlamp.;Alireza Khodadadi-Jamayran.;Glenn I Fishman.
来源: Circ Arrhythm Electrophysiol. 2023年16卷1期e011466页
Patients with chronic kidney disease (CKD) are at increased risk of developing cardiac arrhythmogenesis and sudden cardiac death; however, the basis for this association is incompletely known.
4524. Inappropriate Shock Rates and Long-Term Complications due to Subcutaneous Implantable Cardioverter Defibrillators in Patients With and Without Heart Failure: Results From a Multicenter, International Registry.
作者: Marco Schiavone.;Alessio Gasperetti.;Mikael Laredo.;Alexander Breitenstein.;Julia Vogler.;Pietro Palmisano.;Simone Gulletta.;Carlo Pignalberi.;Carlo Lavalle.;Ennio Pisanò.;Danilo Ricciardi.;Antonio Curnis.;Antonio Dello Russo.;Claudio Tondo.;Nicolas Badenco.;Luigi Di Biase.;Jürgen Kuschyk.;Mauro Biffi.;Roland Tilz.;Giovanni Battista Forleo.; .
来源: Circ Arrhythm Electrophysiol. 2023年16卷1期e011404页 4525. Alternating Early Afterdepolarizations Underlying Bradycardia-Dependent Macroscopic T Wave and Discordant Mechanical Alternans.
作者: Datun Qi.;Wei Li.;Xiao-Qing Quan.;Yuan Gao.;Jianyong Wang.;Lily Guo.;Wenping Zhao.;Tong Liu.;Chuanyu Gao.;Gan-Xin Yan.
来源: Circ Arrhythm Electrophysiol. 2023年16卷1期e011453页
Macroscopic T wave alternans (macro-TWA) often heralds the onset of Torsades de Pointes in patients with QT prolongation. However, the mechanisms underlying macro-TWA remain unclear. We examined the cellular and ionic basis for macro-TWA in rabbits with left ventricular hypertrophy (LVH).
4526. Pleomorphic Ventricular Tachycardia in Dilated Cardiomyopathy Predicts Ventricular Tachycardia Recurrence After Ablation Independent From Cardiac Function: Comparison With Patients With Ischemic Heart Disease.
作者: Yoshitaka Kimura.;Marta de Riva.;Micaela Ebert.;Claire Glashan.;Adrianus P Wijnmaalen.;Sebastiaan R Piers.;Olaf M Dekkers.;Serge A Trines.;Katja Zeppenfeld.
来源: Circ Arrhythm Electrophysiol. 2023年16卷1期e010826页
In dilated cardiomyopathy (DCM), outcome after catheter ablation of ventricular tachycardia (VT) is modest, compared with ischemic heart disease (IHD). Pleomorphic VT (PL-VT) has been associated with fibrotic remodeling and end-stage heart failure in IHD. The prognostic role of PL-VT in DCM is unknown.
4527. Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS.
作者: Anat Milman.;Avi Sabbag.;Giulio Conte.;Pieter G Postema.;Antoine Andorin.;Jean-Baptiste Gourraud.;Frederic Sacher.;Philippe Mabo.;Sung-Hwan Kim.;Shingo Maeda.;Yoshihide Takahashi.;Tsukasa Kamakura.;Takeshi Aiba.;Jimmy Jm Juang.;Yoav Michowitz.;Eran Leshem.;Yuka Mizusawa.;Elena Arbelo.;Zhengrong Huang.;Isabelle Denjoy.;Carla Giustetto.;Yanushi D Wijeyeratne.;Andrea Mazzanti.;Ramon Brugada.;Ruben Casado-Arroyo.;Jean Champagne.;Leonardo Calo.;Georgia Sarquella-Brugada.;Jacob Tfelt-Hansen.;Silvia G Priori.;Masahiko Takagi.;Christian Veltmann.;Pietro Delise.;Domenico Corrado.;Elijah R Behr.;Fiorenzo Gaita.;Gan-Xin Yan.;Josep Brugada.;Antoine Leenhardt.;Arthur A M Wilde.;Pedro Brugada.;Kengo F Kusano.;Kenzo Hirao.;Gi-Byoung Nam.;Vincent Probst.;Bernard Belhassen.
来源: Circ Arrhythm Electrophysiol. 2023年16卷1期e011360页 4528. Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis.
作者: Yunzhou Dong.;Beibei Wang.;Mulong Du.;Bo Zhu.;Kui Cui.;Kathryn Li.;Ke Yuan.;Douglas B Cowan.;Sudarshan Bhattacharjee.;Scott Wong.;Jinjun Shi.;Da-Zhi Wang.;Kaifu Chen.;Joyce Bischoff.;MacRae F Linton.;Hong Chen.
来源: Circulation. 2023年147卷8期669-685页
Epsin endocytic adaptor proteins are implicated in the progression of atherosclerosis; however, the underlying molecular mechanisms have not yet been fully defined. In this study, we determined how epsins enhance endothelial-to-mesenchymal transition (EndoMT) in atherosclerosis and assessed the efficacy of a therapeutic peptide in a preclinical model of this disease.
4529. Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant.
作者: Edgar T Hoorntje.;Charlotte Burns.;Luisa Marsili.;Ben Corden.;Victoria N Parikh.;Gerard J Te Meerman.;Belinda Gray.;Ahmet Adiyaman.;Richard D Bagnall.;Daniela Q C M Barge-Schaapveld.;Maarten P van den Berg.;Marianne Bootsma.;Laurens P Bosman.;Gemma Correnti.;Johan Duflou.;Ruben N Eppinga.;Diane Fatkin.;Michael Fietz.;Eric Haan.;Jan D H Jongbloed.;Arnaud D Hauer.;Lien Lam.;Freyja H M van Lint.;Amrit Lota.;Carlo Marcelis.;Hugh J McCarthy.;Anneke M van Mil.;Rogier A Oldenburg.;Nicholas Pachter.;R Nils Planken.;Chloe Reuter.;Christopher Semsarian.;Jasper J van der Smagt.;Tina Thompson.;Jitendra Vohra.;Paul G A Volders.;Jaap I van Waning.;Nicola Whiffin.;Arthur van den Wijngaard.;Ahmad S Amin.;Arthur A M Wilde.;Gijs van Woerden.;Laura Yeates.;Dominica Zentner.;Euan A Ashley.;Matthew T Wheeler.;James S Ware.;J Peter van Tintelen.;Jodie Ingles.
来源: Circ Genom Precis Med. 2023年16卷1期e003672页
Truncating variants in desmoplakin (DSPtv) are an important cause of arrhythmogenic cardiomyopathy; however the genetic architecture and genotype-specific risk factors are incompletely understood. We evaluated phenotype, risk factors for ventricular arrhythmias, and underlying genetics of DSPtv cardiomyopathy.
4530. Genome-Wide Association and Inheritance-Based Analyses Implicate Unconventional Myosin Genes in Hypoplastic Left Heart Syndrome.
作者: Jeanne L Theis.;Sarah-Dana H Shatila.;Zachary C Fogarty.;William R Bamlet.;Timothy M Olson.
来源: Circ Genom Precis Med. 2023年16卷1期e003761页
Deciphering hypoplastic left heart syndrome (HLHS) pathogenesis is confounded by its genetic heterogeneity and oligogenic underpinnings.
4531. Sex-Specific Survival Bias and Interaction Modeling in Coronary Artery Disease Risk Prediction.
作者: Ida Surakka.;Brooke N Wolford.;Scott C Ritchie.;Whitney E Hornsby.;Nadia R Sutton.;Maiken Elvenstad Gabrielsen.;Anne Heidi Skogholt.;Laurent Thomas.;Michael Inouye.;Kristian Hveem.;Cristen J Willer.
来源: Circ Genom Precis Med. 2023年16卷1期e003542页
The 10-year Atherosclerotic Cardiovascular Disease risk score is the standard approach to predict risk of incident cardiovascular events, and recently, addition of coronary artery disease (CAD) polygenic scores has been evaluated. Although age and sex strongly predict the risk of CAD, their interaction with genetic risk prediction has not been systematically examined. This study performed an extensive evaluation of age and sex effects in genetic CAD risk prediction.
4532. Machine Learning to Understand Genetic and Clinical Factors Associated With the Pulse Waveform Dicrotic Notch.
作者: Jonathan W Cunningham.;Paolo Di Achille.;Valerie N Morrill.;Lu-Chen Weng.;Seung Hoan Choi.;Shaan Khurshid.;Victor Nauffal.;James P Pirruccello.;Scott D Solomon.;Puneet Batra.;Jennifer E Ho.;Anthony A Philippakis.;Patrick T Ellinor.;Steven A Lubitz.
来源: Circ Genom Precis Med. 2023年16卷1期e003676页
Absence of a dicrotic notch on finger photoplethysmography is an easily ascertainable and inexpensive trait that has been associated with age and prevalent cardiovascular disease. However, the trait exists along a continuum, and little is known about its genetic underpinnings or prognostic value for incident cardiovascular disease.
4534. Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context.
Widespread use of contemporary antiretroviral therapy globally has transformed HIV disease into a chronic illness associated with excess risk for disorders of the heart and circulatory system. Current clinical care and research has focused on improving HIV-related cardiovascular disease outcomes, survival, and quality of life. In high-income countries, emphasis on prevention of atherosclerotic coronary artery disease over the past decade, including aggressive management of traditional risk factors and earlier initiation of antiretroviral therapy, has reduced risk for myocardial infarction among persons living with human immunodeficiency virus-1 infection. Still, across the globe, persons living with human immunodeficiency virus-1 infection on effective antiretroviral therapy treatment remain at increased risk for ischemic outcomes such as myocardial infarction and stroke relative to the persons without HIV. Unique features of HIV-related cardiovascular disease, in part, include the pathogenesis of coronary disease characterized by remodeling ectasia and unusual plaque morphology, the relative high proportion of type 2 myocardial infarction events, abnormalities of the aorta such as aneurysms and diffuse aortic inflammation, and HIV cerebrovasculopathy as a contributor to stroke risk. Literature over the past decade has also reflected a shift in the profile and prevalence of HIV-associated heart failure, with a reduced but persistent risk of heart failure with reduced ejection fraction and a growing risk of heart failure with preserved ejection fraction. Cardiac magnetic resonance imaging and autopsy data have emphasized the central importance of intramyocardial fibrosis for the pathogenesis of both heart failure with preserved ejection fraction and the increase in risk of sudden cardiac death. Still, more research is needed to better characterize the underlying mechanisms and clinical phenotype of HIV-associated myocardial disease in the current era. Across the different cardiovascular disease manifestations, a common pathogenic feature is that HIV-associated inflammation working through different mechanisms may amplify underlying pathology because of traditional risk and other host factors. The prevalence and phenotype of individual cardiovascular disease manifestations is ultimately influenced by the degree of injury from HIV disease combined with the profile of underlying cardiometabolic factors, both of which may differ substantially by region globally.
4536. The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum.
作者: Benjamin Essayagh.;Giovanni Benfari.;Clemence Antoine.;Francesco Grigioni.;Thierry Le Tourneau.;Jean-Christian Roussel.;Jeroen J Bax.;Victoria Delgado.;Nina Ajmone Marsan.;Aniek van Wijngaarden.;Christophe Tribouilloy.;Dan Rusinaru.;Aviram Hochstadt.;Yan Topilsky.;Prabin Thapa.;Hector I Michelena.;Maurice Enriquez-Sarano.
来源: Circulation. 2023年147卷10期798-811页
Mitral valve prolapse (MVP) is responsible for a considerable disease burden but is widely heterogeneous. The lack of a comprehensive prognostic instrument covering the entire MVP spectrum, encompassing the quantified consequent degenerative mitral regurgitation (DMR), hinders clinical management and therapeutic trials.
4537. Adults With Congenital Heart Disease: Trends in Event-Free Survival Past Middle Age.
作者: Mikael Dellborg.;Kok Wai Giang.;Peter Eriksson.;Hans Liden.;Maria Fedchenko.;Anders Ahnfelt.;Annika Rosengren.;Zacharias Mandalenakis.
来源: Circulation. 2023年147卷12期930-938页
The survival of children with congenital heart disease has increased substantially over the past decades, with 97% currently reaching adulthood. The total effect of advanced treatment on future mortality and morbidity in adult survivors with congenital heart disease (CHD) is less well described.
4538. Peptide Vaccine Against ADAMTS-7 Ameliorates Atherosclerosis and Postinjury Neointima Hyperplasia.
作者: Zihan Ma.;Chenfeng Mao.;Xiao Chen.;Shiyu Yang.;Zhihua Qiu.;Baoqi Yu.;Yiting Jia.;Chao Wu.;Yiyi Wang.;Yuhui Wang.;Rui Gu.;Fang Yu.;Yanhui Yin.;Xian Wang.;Qingbo Xu.;Chuanju Liu.;Yuhua Liao.;Jingang Zheng.;Yi Fu.;Wei Kong.
来源: Circulation. 2023年147卷9期728-742页
The metalloprotease ADAMTS-7 (a disintegrin and metalloproteinase with thrombospondin type 1 motif 7) is a novel locus associated with human coronary atherosclerosis. ADAMTS-7 deletion protects against atherosclerosis and vascular restenosis in rodents.
4539. Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in Lamin A/C Cardiomyopathy.
作者: Maxime Tremblay-Gravel.;Kenzo Ichimura.;Kermshlise Picard.;Yumeko Kawano.;Annika M Dries.;Francois Haddad.;Neal K Lakdawala.;Matthew T Wheeler.;Victoria N Parikh.
来源: Circ Genom Precis Med. 2023年16卷1期e003480页
In Lamin A/C (LMNA) cardiomyopathy, atrial fibrillation (AF) commonly occurs before dilated cardiomyopathy, and the ability to predict its incidence is limited. We hypothesized that left atrial (LA) echocardiographic phenotyping can identify atrial myopathy and harbingers of AF.
4540. Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†.
作者: Tafadzwa Machipisa.;Chishala Chishala.;Gasnat Shaboodien.;Liesl J Zühlke.;Babu Muhamed.;Shahiemah Pandie.;Jantina de Vries.;Nakita Laing.;Alexia Joachim.;Rezeen Daniels.;Mpiko Ntsekhe.;Christopher T Hugo-Hamman.;Bernard Gitura.;Stephen Ogendo.;Peter Lwabi.;Emmy Okello.;Albertino Damasceno.;Celia Novela.;Ana O Mocumbi.;Geoffrey Madeira.;John Musuku.;Agnes Mtaja.;Ahmed ElSayed.;Huda H M Alhassan.;Fidelia Bode-Thomas.;Christopher Yilgwan.;Ganiyu Amusa.;Esin Nkereuwem.;Nicola Mulder.;Raj Ramesar.;Maia Lesosky.;Heather J Cordell.;Michael Chong.;Bernard Keavney.;Guillaume Paré.;Mark E Engel.; .
来源: Circ Genom Precis Med. 2023年16卷1期e003641页
The genetics of rheumatic heart disease (RHDGen) Network was developed to assist the discovery and validation of genetic variations and biomarkers of risk for rheumatic heart disease (RHD) in continental Africans, as a part of the global fight to control and eradicate rheumatic fever/RHD. Thus, we describe the rationale and design of the RHDGen study, comprising participants from 8 African countries.
|